1/26/2010

A study showed that cancer drug Xeloda combined with Xelox proved more effective than the combination of chemotherapy drugs 5-fluorouracil and leucovorin in improving disease-free survival among elderly patients with colorectal cancer. Xeloda is approved as a monotherapy for those with early-stage colon cancer.

Full Story:
Reuters

Related Summaries